Phase II study of R-CEOP 1-8 for aggressive non-Hodgkin lymphoma in elderly patients

被引：0
|
作者：
Marelli, M.
Bascialla, L.
Chini, C.
Proserpio, I
Gueli, R.
Pinotti, G.
机构：
[1] Azienda Osped Osped Circolo, UO Oncol Med, Varese, Italy
[2] Fdn Macchi, Varese, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI57 / XI57
页数：1
相关论文
共 50 条
  • [41] Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
    Ribrag, Vincent
    Caballero, Dolores
    Ferme, Christophe
    Zucca, Emanuele
    Arranz, Reyes
    Briones, Javier
    Gisselbrecht, Christian
    Salles, Gilles
    Gianni, Alessandro M.
    Gomez, Henry
    Kahatt, Carmen
    Corrado, Claudia
    Szyldergemajn, Sergio
    Extremera, Sonia
    de Miguel, Bernardo
    Cullell-Young, Martin
    Cavalli, Franco
    HAEMATOLOGICA, 2013, 98 (03) : 357 - 363
  • [42] Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory aggressive non-Hodgkin lymphoma
    Wiernik, P. H.
    Lossos, I. S.
    Tuscano, J.
    Justice, G.
    Vose, J. M.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Habermann, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma
    Newell, M
    Goldstein, D
    Milliken, S
    Lewis, C
    Hoy, J
    Thomson, B
    Cooper, D
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 1029 - 1036
  • [44] Phase II study of sphingosomal vincristine in CHOP± rituximab for patients with aggressive non-Hodgkin's lymphoma (NHL):: Promising 3 year follow-up results in elderly patients
    Rodriguez, MA
    Dung, NH
    Fayad, L
    Goy, A
    Hagemeister, F
    McLaughlin, P
    Pro, B
    Romaguera, J
    Younes, A
    Cabanillas, F
    BLOOD, 2005, 106 (11) : 277A - 277A
  • [45] Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma
    Grann, Victor R.
    Hershman, Dawn
    Jacobson, Judith S.
    Tsai, Wei-Yann
    Wang, Jian
    McBride, Russell
    Mitra, Nandita
    Grossbard, Michael L.
    Neugut, Alfred I.
    CANCER, 2006, 107 (07) : 1530 - 1541
  • [46] Role of anemia in survival of elderly aggressive non-Hodgkin's lymphoma patients following chemotherapy.
    Zinzani, PL
    Tani, M
    Molinari, AL
    Visani, G
    Gentilini, P
    Guardigni, L
    Stefoni, V
    Alinari, L
    Marchi, E
    Gabriele, A
    Musuraca, G
    Fina, MP
    Baccarani, M
    BLOOD, 2004, 104 (11) : 906A - 906A
  • [47] Prognostic significance of geriatric assessment in combination with laboratory parameters in elderly patients with aggressive non-Hodgkin lymphoma
    Aaldriks, Ab A.
    Giltay, Erik J.
    Nortier, Johan W. R.
    van der Geest, Lydia G. M.
    Tanis, Bea C.
    Ypma, Paula
    le Cessie, Saskia
    Maartense, Ed
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 927 - 935
  • [48] Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist
    Schmittlutz, Katrin
    Marks, Reinhard
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [49] A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma
    Ohmachi, Ken
    Ogura, Michinori
    Kagami, Yoshitoyo
    Imai, Yosuke
    Hirose, Takayuki
    Kinoshita, Tomohiro
    Nagai, Hirokazu
    Ohnishi, Kazunori
    Hotta, Tomomitsu
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2022, 62 (04) : 202 - 207
  • [50] The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma
    Goldschmidt, Neta
    Or, Omer
    Klein, Martine
    Savitsky, Bella
    Paltiel, Ora
    ANNALS OF HEMATOLOGY, 2011, 90 (02) : 165 - 171
12345